# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-001296
Filing Date
2025-03-28
Accepted
2025-03-28 17:19:42
Documents
92
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 1967971
2 |  | ex10-14.htm | EX-10.14 | 49695
3 |  | ex10-37.htm | EX-10.37 | 340140
4 |  | ex21.htm | EX-21 | 6279
5 |  | ex23-1.htm | EX-23.1 | 4201
6 |  | ex31-1.htm | EX-31.1 | 12700
7 |  | ex31-2.htm | EX-31.2 | 12920
8 |  | ex32.htm | EX-32 | 9180
9 |  | ex10-37_01.jpg | GRAPHIC | 2319
10 |  | ex10-37_02.jpg | GRAPHIC | 2275
| Complete submission text file | 0001641172-25-001296.txt |  | 9320576

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL SCHEMA FILE | envb-20241231.xsd | EX-101.SCH | 70680
12 | XBRL CALCULATION FILE | envb-20241231_cal.xml | EX-101.CAL | 80210
13 | XBRL DEFINITION FILE | envb-20241231_def.xml | EX-101.DEF | 292967
14 | XBRL LABEL FILE | envb-20241231_lab.xml | EX-101.LAB | 611910
15 | XBRL PRESENTATION FILE | envb-20241231_pre.xml | EX-101.PRE | 468125
94 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 1255029

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38286 | Film No.: 25787789
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)